{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2018:IYTY7A5IY253P2I3KFSEIOCV63","short_pith_number":"pith:IYTY7A5I","canonical_record":{"source":{"id":"1810.00867","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2018-09-28T23:58:23Z","cross_cats_sorted":["stat.ML"],"title_canon_sha256":"5a7d0a80af83dd46e50fb5df9e7766535529e7b7d6b578dafa37ce93c46ed9e6","abstract_canon_sha256":"add7ce03b5203486d4ceb92e55cc2e00950e7585d09bd8976049bf2225df89bb"},"schema_version":"1.0"},"canonical_sha256":"46278f83a8c6bbb7e91b5164443855f6f17d245c28c40a9b1f96179797d6b570","source":{"kind":"arxiv","id":"1810.00867","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1810.00867","created_at":"2026-05-18T00:04:19Z"},{"alias_kind":"arxiv_version","alias_value":"1810.00867v1","created_at":"2026-05-18T00:04:19Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1810.00867","created_at":"2026-05-18T00:04:19Z"},{"alias_kind":"pith_short_12","alias_value":"IYTY7A5IY253","created_at":"2026-05-18T12:32:31Z"},{"alias_kind":"pith_short_16","alias_value":"IYTY7A5IY253P2I3","created_at":"2026-05-18T12:32:31Z"},{"alias_kind":"pith_short_8","alias_value":"IYTY7A5I","created_at":"2026-05-18T12:32:31Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2018:IYTY7A5IY253P2I3KFSEIOCV63","target":"record","payload":{"canonical_record":{"source":{"id":"1810.00867","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2018-09-28T23:58:23Z","cross_cats_sorted":["stat.ML"],"title_canon_sha256":"5a7d0a80af83dd46e50fb5df9e7766535529e7b7d6b578dafa37ce93c46ed9e6","abstract_canon_sha256":"add7ce03b5203486d4ceb92e55cc2e00950e7585d09bd8976049bf2225df89bb"},"schema_version":"1.0"},"canonical_sha256":"46278f83a8c6bbb7e91b5164443855f6f17d245c28c40a9b1f96179797d6b570","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:04:19.759091Z","signature_b64":"grEkCjwYFfx2rYYj9EUFvhsfMIYLWNMI14f+KVfuiuwViRib8JFGl4BT5pVvBfpAc7+wlBjYuz4z8FzmbDTnAw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"46278f83a8c6bbb7e91b5164443855f6f17d245c28c40a9b1f96179797d6b570","last_reissued_at":"2026-05-18T00:04:19.758463Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:04:19.758463Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1810.00867","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:04:19Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"8ABA94OeBZ9dHekSYFqXShDVTAVpCBc4wXmrI9JuwEmu69Vl/+BhDV7GXjsD+W76FhqBYl7sa7oeL7YOkHkOAA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-03T10:55:40.319798Z"},"content_sha256":"3f32226e220206d8ae4b0910fcd02f1e54e8b61f64fde4e8ec1f261a78e332f2","schema_version":"1.0","event_id":"sha256:3f32226e220206d8ae4b0910fcd02f1e54e8b61f64fde4e8ec1f261a78e332f2"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2018:IYTY7A5IY253P2I3KFSEIOCV63","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Domain-Adversarial Multi-Task Framework for Novel Therapeutic Property Prediction of Compounds","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["stat.ML"],"primary_cat":"cs.LG","authors_text":"Boyuan Feng, Kun Wan, Lingwei Xie, Shu Yang, Song He, Xiaochen Bo, Yufei Ding, Zhongnan Zhang","submitted_at":"2018-09-28T23:58:23Z","abstract_excerpt":"With the rapid development of high-throughput technologies, parallel acquisition of large-scale drug-informatics data provides huge opportunities to improve pharmaceutical research and development. One significant application is the purpose prediction of small molecule compounds, aiming to specify therapeutic properties of extensive purpose-unknown compounds and to repurpose novel therapeutic properties of FDA-approved drugs. Such problem is very challenging since compound attributes contain heterogeneous data with various feature patterns such as drug fingerprint, drug physicochemical propert"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1810.00867","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:04:19Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"3R4v06/+OkG7GB2eUynHEHUDNpuZeqk7G8C4TsEi8vl7yO6H+PJSyehnAc5oXlPMYBaAvCsFG8VWY1HIgqkCBw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-03T10:55:40.320150Z"},"content_sha256":"f67a1beb13bb48979d023215650cf033292932b51bedb2974cb425e0a8b1162c","schema_version":"1.0","event_id":"sha256:f67a1beb13bb48979d023215650cf033292932b51bedb2974cb425e0a8b1162c"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/IYTY7A5IY253P2I3KFSEIOCV63/bundle.json","state_url":"https://pith.science/pith/IYTY7A5IY253P2I3KFSEIOCV63/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/IYTY7A5IY253P2I3KFSEIOCV63/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-03T10:55:40Z","links":{"resolver":"https://pith.science/pith/IYTY7A5IY253P2I3KFSEIOCV63","bundle":"https://pith.science/pith/IYTY7A5IY253P2I3KFSEIOCV63/bundle.json","state":"https://pith.science/pith/IYTY7A5IY253P2I3KFSEIOCV63/state.json","well_known_bundle":"https://pith.science/.well-known/pith/IYTY7A5IY253P2I3KFSEIOCV63/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2018:IYTY7A5IY253P2I3KFSEIOCV63","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"add7ce03b5203486d4ceb92e55cc2e00950e7585d09bd8976049bf2225df89bb","cross_cats_sorted":["stat.ML"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2018-09-28T23:58:23Z","title_canon_sha256":"5a7d0a80af83dd46e50fb5df9e7766535529e7b7d6b578dafa37ce93c46ed9e6"},"schema_version":"1.0","source":{"id":"1810.00867","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1810.00867","created_at":"2026-05-18T00:04:19Z"},{"alias_kind":"arxiv_version","alias_value":"1810.00867v1","created_at":"2026-05-18T00:04:19Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1810.00867","created_at":"2026-05-18T00:04:19Z"},{"alias_kind":"pith_short_12","alias_value":"IYTY7A5IY253","created_at":"2026-05-18T12:32:31Z"},{"alias_kind":"pith_short_16","alias_value":"IYTY7A5IY253P2I3","created_at":"2026-05-18T12:32:31Z"},{"alias_kind":"pith_short_8","alias_value":"IYTY7A5I","created_at":"2026-05-18T12:32:31Z"}],"graph_snapshots":[{"event_id":"sha256:f67a1beb13bb48979d023215650cf033292932b51bedb2974cb425e0a8b1162c","target":"graph","created_at":"2026-05-18T00:04:19Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"With the rapid development of high-throughput technologies, parallel acquisition of large-scale drug-informatics data provides huge opportunities to improve pharmaceutical research and development. One significant application is the purpose prediction of small molecule compounds, aiming to specify therapeutic properties of extensive purpose-unknown compounds and to repurpose novel therapeutic properties of FDA-approved drugs. Such problem is very challenging since compound attributes contain heterogeneous data with various feature patterns such as drug fingerprint, drug physicochemical propert","authors_text":"Boyuan Feng, Kun Wan, Lingwei Xie, Shu Yang, Song He, Xiaochen Bo, Yufei Ding, Zhongnan Zhang","cross_cats":["stat.ML"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2018-09-28T23:58:23Z","title":"Domain-Adversarial Multi-Task Framework for Novel Therapeutic Property Prediction of Compounds"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1810.00867","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:3f32226e220206d8ae4b0910fcd02f1e54e8b61f64fde4e8ec1f261a78e332f2","target":"record","created_at":"2026-05-18T00:04:19Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"add7ce03b5203486d4ceb92e55cc2e00950e7585d09bd8976049bf2225df89bb","cross_cats_sorted":["stat.ML"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2018-09-28T23:58:23Z","title_canon_sha256":"5a7d0a80af83dd46e50fb5df9e7766535529e7b7d6b578dafa37ce93c46ed9e6"},"schema_version":"1.0","source":{"id":"1810.00867","kind":"arxiv","version":1}},"canonical_sha256":"46278f83a8c6bbb7e91b5164443855f6f17d245c28c40a9b1f96179797d6b570","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"46278f83a8c6bbb7e91b5164443855f6f17d245c28c40a9b1f96179797d6b570","first_computed_at":"2026-05-18T00:04:19.758463Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:04:19.758463Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"grEkCjwYFfx2rYYj9EUFvhsfMIYLWNMI14f+KVfuiuwViRib8JFGl4BT5pVvBfpAc7+wlBjYuz4z8FzmbDTnAw==","signature_status":"signed_v1","signed_at":"2026-05-18T00:04:19.759091Z","signed_message":"canonical_sha256_bytes"},"source_id":"1810.00867","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:3f32226e220206d8ae4b0910fcd02f1e54e8b61f64fde4e8ec1f261a78e332f2","sha256:f67a1beb13bb48979d023215650cf033292932b51bedb2974cb425e0a8b1162c"],"state_sha256":"ebb74004280403a402053543080cf7251851f3754aecd069611f50e137bd28f2"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"oeEZ0JgUWjddfj1VmpRfLyF7/TDR2z5EkMvqqw5oP6ei1UxwrQGvc8ui9WaSuralmnjjpeZFvKf002thxQWlBQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-03T10:55:40.322175Z","bundle_sha256":"d7316b326aa3e1585bec3ff9859153dbcb4f67fe1e11dea1fd34631b1dbffb72"}}